Incyte Corp (INCY)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$97.67

Buy

$97.75

arrow-up$0.68 (+0.70%)

Prices updated at 17 Dec 2025, 19:55 EST

Prices minimum 15 mins delay

Prices in USD

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.

NASDAQ

-1.49%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$98.90 - $97.09
	$109.28 - $53.56
	-
	19,047.23m
	16.45
	-
	505,926
	4.10
	1,954,684.01
	1.02
	193.43m
	US45337C1027
	5.90
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.